Skip to content
Storytelling Co – Lifestyle
Author:
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
September 10, 2026
Type 1 Diabetes Therapy: Sernova & Seraxis Merge to Form BetaNova
September 8, 2026
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
June 17, 2026